Astrocytic regulation of glutamate homeostasis in epilepsy

GLIA

Volumn 60, Issue 8, 2012, Pages 1215-1226

  Coulter, Douglas A ^a   Eid, Tore ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Epilepsy; Glutamate; Glutamine; Metabolism

Indexed keywords

GLUTAMIC ACID; GLUTAMINE;

AMINO ACID SYNTHESIS; ASTROCYTE; ASTROCYTOSIS; CELL TRANSPORT; EPILEPSY; EXCITOTOXICITY; HOMEOSTASIS; HUMAN; KETOGENIC DIET; METABOLIC CLEARANCE RATE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ASTROCYTES; EPILEPSY; GLUTAMIC ACID; HOMEOSTASIS; HUMANS;

EID: 84862321615     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22341     Document Type: Review

References (149)

1. Akbar MT, Torp R, Danbolt NC, Levy LM, Meldrum BS, Ottersen OP. 1997. Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats. Neuroscience 78: 351-359.
2. Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. 2010. Mechanisms of oxidative glutamate toxicity: The glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets 9: 373-382.
3. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. 2006. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47: 867-872.
4. Ang CW, Carlson GC, Coulter DA. 2005. Hippocampal CA1 circuitry dynamically gates direct cortical inputs preferentially at theta frequencies. J Neurosci 25: 9567-9580.
5. Ang CW, Carlson GC, Coulter DA. 2006. Massive and specific dysregulation of direct cortical input to the hippocampus in temporal lobe epilepsy. J Neurosci 26: 11850-11856.
6. Araque A, Li N, Doyle RT, Haydon PG. 2000. SNARE protein-dependent glutamate release from astrocytes. J Neurosci 20: 666-673.
7. Attwell D. 1994. Glia and neurons in dialogue. Nature 369: 707-708.
8. Bacci A, Sancini G, Verderio C, Armano S, Pravettoni E, Fesce R, Franceschetti S, Matteoli M. 2002. Block of glutamate-glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus. J Neurophysiol 88: 2302-2310.
9. Battaglioli G, Martin DL. 1991. GABA synthesis in brain slices is dependent on glutamine produced in astrocytes. Neurochem Res 16: 151-156.
10. Beer J, Mielke K, Zipp M, Zimmermann M, Herdegen T. 1998. Expression of c-jun, junB, c-fos, fra-1 and fra-2 mRNA in the rat brain following seizure activity and axotomy. Brain Res 794: 255-266.
11. Bellocchio EE, Hu H, Pohorille A, Chan J, Pickel VM, Edwards RH. 1998. The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci 18: 8648-8659.
12. Ben-Ari Y. 1985. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
13. Benjamin AM, Quastel JH. 1975. Metabolism of amino acids and ammonia in rat brain cortex slices in vitro: A possible role of ammonia in brain function. J Neurochem 25: 197-206.
14. Bergersen LH. 2007. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience 145: 11-19.
15. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391: 281-285.
16. Bidmon HJ, Gorg B, Palomero-Gallagher N, Schleicher A, Haussinger D, Speckmann EJ, Zilles K. 2008. Glutamine synthetase becomes nitrated and its activity is reduced during repetitive seizure activity in the pentylentetrazole model of epilepsy. Epilepsia 49: 1733-1748.
17. Bouchet C. 1825. De l'épilepsie considérée dans ses rapports avec l'aliénation mentale. Recherche sur la nature et le siége de ces deux maladies. Arch Gén Méd 9: 510-42.
18. Bough K. 2008. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia 49(Suppl 8): 91-93.
19. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. 1998. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166-1172.
20. Brun VH, Otnass MK, Molden S, Steffenach HA, Witter MP, Moser MB, Moser EI. 2002. Place cells and place recognition maintained by direct entorhinal-hippocampal circuitry. Science 296: 2243-2246.
21. Bryant AS, Li B, Beenhakker MP, Huguenard JR. 2009. Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle. J Neurophysiol 102: 2880-2888.
22. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. 1992. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89: 2115-2119.
23. Butterworth RF. 2010. Altered glial-neuronal crosstalk: Cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem Int 57: 383-388.
24. Buzsaki G, Penttonen M, Bragin A, Nadasdy Z, Chrobak JJ. 1995. Possible physiological role of the perforant path-CA1 projection. Hippocampus 5: 141-146.
25. Cantello R, Varrasi C, Tarletti R, Cecchin M, D'Andrea F, Veggiotti P, Bellomo G, Monaco F. 2007. Ketogenic diet: Electrophysiological effects on the normal human cortex. Epilepsia 48: 1756-1763.
26. Cavus I, Kasoff WS, Cassaday MP, Jacob R, Gueorguieva R, Sherwin RS, Krystal JH, Spencer DD, Abi-Saab WM. 2005. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 57: 226-235.
27. Chaudhry FA, Reimer RJ, Edwards RH. 2002. The glutamine commute: Take the N line and transfer to the A. J Cell Biol 157: 349-355.
28. Choi DW, Hartley DM. 1993. Calcium and glutamate-induced cortical neuronal death. In: Waxman SG, editor. Molecular and cellular approaches to the treatment of neurologic disease. New York: Raven Press.
29. Cohen-Gadol AA, Pan JW, Kim JH, Spencer DD, Hetherington HH. 2004. Mesial temporal lobe epilepsy: A proton magnetic resonance spectroscopy study and a histopathological analysis. J Neurosurg 101: 613-620.
30. Cohen AS, Lin DD, Quirk GL, Coulter DA. 2003. Dentate granule cell GABA(A) receptors in epileptic hippocampus: Enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci 17: 1607-1616.
31. Coulter DA. 2001. Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties. Int Rev Neurobiol 45: 237-252.
32. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65: 1-105.
33. de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid T, Spencer DD. 2003. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: Evidence for distinctive patient subcategories. Epilepsia 44: 677-687.
34. Dennis SC, Lai JC, Clark JB. 1977. Comparative studies on glutamate metabolism in synpatic and non-synaptic rat brain mitochondria. Biochem J 164: 727-736.
35. Denslow MJ, Eid T, Du F, Schwarcz R, Lothman EW, Steward O. 2001. Disruption of inhibition in area CA1 of the hippocampus in a rat model of temporal lobe epilepsy. J Neurophysiol 86: 2231-2245.
36. Du F, Whetsell WOJr, Abou-Khalil B, Blumenkopf B, Lothman EW, Schwarcz R. 1993. Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res 16: 223-233.
37. During MJ, Spencer DD. 1993. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341: 1607-1610.
38. Eid T, Ghosh A, Wang Y, Beckstrom H, Zaveri HP, Lee TS, Lai JC, Malthankar-Phatak GH, de Lanerolle NC. 2008a. Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats. Brain 131: 2061-2070.
39. Eid T, Thomas MJ, Spencer DD, Runden-Pran E, Lai JC, Malthankar GV, Kim JH, Danbolt NC, Ottersen OP, de Lanerolle NC. 2004. Loss of glutamine synthetase in the human epileptogenic hippocampus: Possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 363: 28-37.
40. Eid T, Williamson A, Lee TS, Petroff OA, de Lanerolle NC. 2008b. Glutamate and astrocytes-Key players in human mesial temporal lobe epilepsy? Epilepsia 49(Suppl 2): 42-52.
41. Empson RM, Heinemann U. 1995. The perforant path projection to hippocampal area CA1 in the rat hippocampal-entorhinal cortex combined slice. J Physiol 484(Pt 3): 707-720.
42. Eulenburg V, Gomeza J. 2010. Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res Rev 63: 103-112.
43. Folbergrova J, Passonneau JV, Lowry OH, Schulz DW. 1969. Glycogen, ammonia and related metabolities in the brain during seizures evoked by methionine sulphoximine. J Neurochem 16: 191-203.
44. Fonnum F. 1984. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 42: 1-11.
45. Fremeau RTJr, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, Edwards RH. 2002. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA 99: 14488-14493.
46. Fremeau RTJr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH. 2001. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31: 247-260.
47. Fricke MN, Jones-Davis DM, Mathews GC. 2007. Glutamine uptake by System A transporters maintains neurotransmitter GABA synthesis and inhibitory synaptic transmission. J Neurochem 102: 1895-1904.
48. Gibbs JWIII, Shumate MD, Coulter DA. 1997. Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J Neurophysiol 77: 1924-1938.
49. Gloor P. 1991. Mesial temporal sclerosis: Historical background and an overview from a modern perspective. In: Luders H, editor. Epilepsy surgery. New York: Raven Press. pp 689-703.
50. Gorg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, Haussinger D. 2010. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 52: 256-265.
51. Halestrap AP, Price NT. 1999. The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem J 343: 281-299.
52. Hamilton NB, Attwell D. 2010. Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11: 227-238.
53. Hawkins RA, DeJoseph MR, Hawkins PA. 1995. Regional brain glutamate transport in rats at normal and raised concentrations of circulating glutamate. Cell Tissue Res 281: 207-214.
54. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. 1996. Dementia and adult-onset unprovoked seizures. Neurology 46: 727-730.
55. Huang TL, O'Banion MK. 1998. Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes. J Neurochem 71: 1436-1442.
56. Huttenlocher PR. 1976. Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 10: 536-540.
57. Innocenti B, Parpura V, Haydon PG. 2000. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes. J Neurosci 20: 1800-1808.
58. Jabs R, Seifert G, Steinhauser C. 2008. Astrocytic function and its alteration in the epileptic brain. Epilepsia 49(Suppl 2): 3-12.
59. Jackson MJ, Zielke HR, Max SR. 1995. Effect of dibutyryl cyclic AMP and dexamethasone on glutamine synthetase gene expression in rat astrocytes in culture. Neurochem Res 20: 201-207.
60. Jenstad M, Quazi AZ, Zilberter M, Haglerod C, Berghuis P, Saddique N, Goiny M, Buntup D, Davanger S, Haug FMS, Barnes CA, McNaughton BL, Ottersen OP, Storm-Mathisen J, Harkany T, Chaudhry FA. 2009. System A transporter SAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by glutamate. Cereb Cortex 19: 1092-1106.
61. Jin H, Wu H, Osterhaus G, Wei J, Davis K, Sha D, Floor E, Hsu CC, Kopke RD, Wu JY. 2003. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci USA 100: 4293-4298.
62. Kam K, Nicoll R. 2007. Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. J Neurosci 27: 9192-9200.
63. Kelly T, Kafitz KW, Roderigo C, Rose CR. 2009. Ammonium-evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity. Glia 57: 921-934.
64. Kim JH, Je S, Petroff OA, Spencer SS, Hwang JY, Spencer DD. 2004. Hippocampal glial density in temporal lobe epilepsy. Epilepsia 45: S33-S34.
65. Kimelberg HK, Goderie SK, Higman S, Pang S, Waniewski RA. 1990. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 10: 1583-1591.
66. Kimelberg HK, Rutledge E, Goderie S, Charniga C. 1995. Astrocytic swelling due to hypotonic or high K+ medium causes inhibition of glutamate and aspartate uptake and increases their release. J Cereb Blood Flow Metab 15: 409-416.
67. Kruchkova Y, Ben-Dror I, Herschkovitz A, David M, Yayon A, Vardimon L. 2001. Basic fibroblast growth factor: A potential inhibitor of glutamine synthetase expression in injured neural tissue. J Neurochem 77: 1641-1649.
68. Kvamme E, Roberg B, Torgner IA. 2001. Kinetics and localization of phosphate activated glutaminase. J Neurosci Res 66: 951-958.
69. Lajtha A, Berl S, Waelsch H. 1959. Amino acid and protein metabolism of the brain. IV. The metabolism of glutamic acid. J Neurochem 3: 322-332.
70. Lamigeon C, Bellier JP, Sacchettoni S, Rujano M, Jacquemont B. 2001. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J Neurochem 77: 598-606.
71. Lauritzen F, de Lanerolle NC, Lee TS, Spencer DD, Kim JH, Bergersen LH, Eid T. 2011. Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus. Neurobiol Dis 41: 577-584.
72. Lauritzen F, Perez EL, Melillo ER, Roh JM, Zaveri HP, Lee TS, Wang Y, Bergersen LH, Eid T. 2012. Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy. Neurobiol Dis 45: 165-176.
73. Lee TS, Bjornsen LP, Paz C, Kim JH, Spencer SS, Spencer DD, Eid T, de Lanerolle NC. 2006. GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus. Acta Neuropathol (Berl) 111: 351-363.
74. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. 2001. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 38: 519-527.
75. Leke R, Bak LK, Iversen P, Sorensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Schousboe A, Waagepetersen HS. 2011. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. J Neurochem 117: 824-832.
76. Liang SL, Carlson GC, Coulter DA. 2006. Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1. J Neurosci 26: 8537-8548.
77. Liu Z, Holmes GL. 1997. Basic fibroblast growth factor-induced seizures in rats. Neurosci Lett 233: 85-88.
78. Lomako J, Lomako WM, Whelan WJ, Dombro RS, Neary JT, Norenberg MD. 1993. Glycogen synthesis in the astrocyte: From glycogenin to proglycogen to glycogen. FASEB J 7: 1386-1393.
79. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. 1999. Energy on demand. Science 283: 496-497.
80. Magistretti PJ, Sorg O, Yu N, Martin J-L, Pellerin L. 1993. Neurotransmitters regulate energy metabolism in astrocytes: Implications for metabolic trafficking between neural cells. Dev Neurosci 15: 306-312.
81. Malthankar-Phatak GH, de Lanerolle N, Eid T, Spencer DD, Behar KL, Spencer SS, Kim JH, Lai JC. 2006. Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy. Epilepsia 47: 1292-1299.
82. Martinez-Hernandez A, Bell KP, Norenberg MD. 1977. Glutamine synthetase: Glial localization in brain. Science 195: 1356-1358.
83. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP, Chimelli L, Born DE, et al. 1999. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52: 453-472.
84. Mathews GC, Diamond JS. 2003. Neuronal glutamate uptake Contributes to GABA synthesis and inhibitory synaptic strength. J Neurosci 23: 2040-2048.
85. Meldrum B. 1991. Excitotoxicity and epileptic brain damage. Epilepsy Res 10: 55-61.
86. Meldrum BS. 1986. Cell damage in epilepsy and the role of calcium in cytotoxicity. Adv Neurol 44: 849-855.
87. Miller HP, Levey AI, Rothstein JD, Tzingounis AV, Conn PJ. 1997. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J Neurochem 68: 1564-1570.
88. Morris AA. 2005. Cerebral ketone body metabolism. J Inherit Metab Dis 28: 109-121.
89. Nadler J, Cuthbertson G. 1980. Kainic acid neurotoxicity toward the hippocampal formation: Dependence on specific excitatory pathways. Brain Res 195: 47-56.
90. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. 2011. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: Mechanism for deficient glutamatergic transmission? Mol Neurodegener 6: 55.
91. Olney JW, Collins RC, Sloviter RS. 1986. Excitotoxic mechanims of epileptic brain damage. In: Delgado-Escueta AV, Ward AAJr, Woodbury DM, Porter RJ, editors. Advances in neurology. New York: Raven Press. pp 857-877.
92. Olney JW, Sharpe LG, Feigin RD. 1972. Glutamate-induced brain damage in infant primates. J Neuropathol Exp Neurol 31: 464-488.
93. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA. 2010. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13: 584-591.
94. Otis TS, Jahr CE. 1998. Anion currents and predicted glutamate flux through a neuronal glutamate transporter. J Neurosci 18: 7099-7110.
95. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. 2007. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55: 697-711.
96. Palop JJ, Mucke L. 2009. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66: 435-440.
97. Pan JW, Bebin EM, Chu WJ, Hetherington HP. 1999. Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia 40: 703-707.
98. Papageorgiou IE, Gabriel S, Fetani AF, Kann O, Heinemann U. 2011. Redistribution of astrocytic glutamine synthetase in the hippocampus of chronic epileptic rats. Glia 59: 1706-1718.
99. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. 1994. Glutamate-mediated astrocyte-neuron signalling. Nature 369: 744-747.
100. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50: 427-434.
101. Pellerin L, Bergersen LH, Halestrap AP, Pierre K. 2005. Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res 79: 55-64.
102. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL, Stella N, Magistretti PJ. 1998. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20: 291-299.
103. Peters A, Palay SL, Webster Hd. 1991. The fine structure of the nervous system. Neurons and their supporting cells. New York: Oxford University Press.
104. Petroff OA, Cavus I, Kim JH, Spencer DD. 2004. Interictal extracellular glutamate concentrations are increased in hippocampal sclerosis. Ann Neurol 56: S43.
105. Petroff OA, Errante LD, Kim JH, Spencer DD. 2003. N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus. Neurology 60: 1646-1651.
106. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. 2002. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43: 703-710.
107. Pinal CS, Tobin AJ. 1998. Uniqueness and redundancy in GABA production. Perspect Dev Neurobiol 5: 109-118.
108. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH, van Veelen CW, van Rijen PC, van Nieuwenhuizen O, Gispen WH, de Graan PN. 2002. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125: 32-43.
109. Qutub AA, Hunt CA. 2005. Glucose transport to the brain: A systems model. Brain Res Brain Res Rev 49: 595-617.
110. Rae C, Hare N, Bubb WA, McEwan SR, Broer A, McQuillan JA, Balcar VJ, Conigrave AD, Broer S. 2003. Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: Further evidence for metabolic compartmentation. J Neurochem 85: 503-514.
111. Rice A, Rafiq A, Shapiro SM, Jakoi ER, Coulter DA, DeLorenzo RJ. 1996. Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci USA 93: 9665-9669.
112. Romanelli MF, Morris JC, Ashkin K, Coben LA. 1990. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 47: 847-850.
113. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kunci RW, Kanai Y, Schielke JP, Welty DF. 1996. Konckout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
114. Rusakov DA, Kullmann DM. 1998. Extrasynaptic glutamate diffusion in the hippocampus: Ultrastructural constraints, uptake, and receptor activation. J Neurosci 18: 3158-3170.
115. Sandow N, Zahn RK, Gabriel S, Heinemann U, Lehmann TN. 2009. Glutamine induces epileptiform discharges in superficial layers of the medial entorhinal cortex from pilocarpine-treated chronic epileptic rats in vitro. Epilepsia 50: 849-858.
116. Santello M, Bezzi P, Volterra A. 2011. TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69: 988-1001.
117. Schousboe A. 1981. Transport and metabolism of glutamate and GABA in neurons are glial cells. Int Rev Neurobiol 22: 1-45.
118. Schwartz RM, Boyes S, Aynsley-Green A. 1989. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol 31: 152-160.
119. Seifert G, Carmignoto G, Steinhauser C. 2010. Astrocyte dysfunction in epilepsy. Brain Res Rev 63: 212-221.
120. Seifert G, Schilling K, Steinhauser C. 2006. Astrocyte dysfunction in neurological disorders: A molecular perspective. Nat Rev Neurosci 7: 194-206.
121. Sepkuty JP, Cohen AS, Eccles C, Rafiq A, Behar K, Ganel R, Coulter DA, Rothstein JD. 2002. A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci 22: 6372-6379.
122. Shank RP, Bennett GS, Freytag SO, Campbell GL. 1985. Pyruvate carboxylase: An astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329: 364-367.
123. Simantov R, Crispino M, Hoe W, Broutman G, Tocco G, Rothstein JD, Baudry M. 1999. Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Res Mol Brain Res 65: 112-123.
124. Smith QR. 2000. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 130: 1016S-22S.
125. Solbu TT, Bjorkmo M, Berghuis P, Harkany T, Chaudhry FA. 2010. SAT1, a glutamine transporter, is preferentially expressed in GABAergic neurons. Front Neuroanat 4: 1.
126. Soltesz I. 1995. Brief history of cortico-hippocampal time with a special reference to the direct entorhinal input to CA1. Hippocampus 5: 120-124.
127. Sommer W. 1880. Erkrankung des Ammonshorns als aetiologisches Moment der Epilepsie. Arch Psychiatr Nervenkr 10: 631-675.
128. Spencer SS. 2002. Neural networks in human epilepsy: Evidence of and implications for treatment. Epilepsia 43: 219-227.
129. Spencer SS, Spencer DD. 1994. Entorhinal-hippocampal interactions in medial temporal lobe epilepsy. Epilepsia 35: 721-727.
130. Stafstrom C, Vining EPG, Rho JM. 2007. Ketogenic diet. In: Engel J, Pedley TA, editors. Epilepsy: A comprehensive textbook. Lippincott Williams & Wilkins. pp 1377-1386.
131. Stanimirovic DB, Ball R, Small DL, Muruganandam A. 1999. Developmental regulation of glutamate transporters and glutamine synthetase activity in astrocyte cultures differentiated in vitro. Int J Dev Neurosci 17: 173-184.
132. Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J, Ishii E. 2009. Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res 1268: 17-23.
133. Svenneby G. 1970. Pig brain glutaminase: Purification and identification of different enzyme forms. J Neurochem 17: 1591-1599.
134. Takamori S, Malherbe P, Broger C, Jahn R. 2002. Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep 3: 798-803.
135. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702.
136. Tani H, Dulla CG, Huguenard JR, Reimer RJ. 2010. Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice. J Neurosci 30: 1288-1300.
137. Tessler S, Danbolt NC, Faull RL, Storm-Mathisen J, Emson PC. 1999. Expression of the glutamate transporters in human temporal lobe epilepsy. Neuroscience 88: 1083-1091.
138. Tzingounis AV, Wadiche JI. 2007. Glutamate transporters: Confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci 8: 935-947.
139. van den Berg CJ, Garfinkel D. 1971. A stimulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J 123: 211-218.
140. van der Hel WS, Notenboom RG, Bos IW, van Rijen PC, van Veelen CW, de Graan PN. 2005. Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology 64: 326-333.
141. Vaquero J, Chung C, Blei AT. 2003. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2: 12-22.
142. Vardimon L, Ben-Dror I, Avisar N, Oren A, Shiftan L. 1999. Glucocorticoid control of glial gene expression. J Neurobiol 40: 513-527.
143. Waagepetersen HS, Sonnewald U, Schousboe A. 1999. The GABA paradox: Multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J Neurochem 73: 1335-1342.
144. Wang Y, Zaveri HP, Lee TS, Eid T. 2009. The development of recurrent seizures after continuous intrahippocampal infusion of methionine sulfoximine in rats: A video-intracranial electroencephalographic study. Exp Neurol 220: 293-302.
145. Watanabe T, Morimoto K, Hirao T, Suwaki H, Watase K, Tanaka K. 1999. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res 845: 92-96.
146. Williamson A, Patrylo PR, Pan J, Spencer DD, Hetherington H. 2005. Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy. Brain 128: 1199-1208.
147. Wozny C, Gabriel S, Jandova K, Schulze K, Heinemann U, Behr J. 2005. Entorhinal cortex entrains epileptiform activity in CA1 in pilocarpine-treated rats. Neurobiol Dis 19: 451-460.
148. Yang S, Cox CL. 2011. Attenuation of inhibitory synaptic transmission by glial dysfunction in rat thalamus. Synapse 65: 1298-1308.
149. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I. 2004. Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids 70: 277-285.